Enlivex Therapeutics Ltd. (ENLV) vs Soligenix, Inc. (SNGX)
A side-by-side comparison of Enlivex Therapeutics Ltd. and Soligenix, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ENLV
Enlivex Therapeutics Ltd.
$0.34HealthcareDelayed quote: Oct 6, 2026, 3:37 PM EDT
SNGX
Soligenix, Inc.
$0.36HealthcareDelayed quote: Oct 6, 2026, 3:33 PM EDT
Total return — ENLV vs SNGX
growth of $100 · dividends reinvested · last 10yENLV -100.0% (-54.7%/yr)SNGX -100.0% (-57.6%/yr)ENLV compounded faster over this window
ENLV SNGX
ENLV vs SNGX: by the numbers
- •ENLV is the larger company ($6M vs $5M market cap).
Metrics side by side
Valuation
| Metric | ENLV | SNGX |
|---|---|---|
| P/E ratio | 0.00 | N/A |
| P/B ratio | 0.00 | 0.80 |
Profitability
| Metric | ENLV | SNGX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | 105.35% | -154.08% |
| ROIC | -0.32% | -161.69% |
Growth (annualized)
| Metric | ENLV | SNGX |
|---|---|---|
| Total return CAGR (5Y) | -69.81% | -72.72% |
Frequently asked
- How have ENLV and SNGX total returns compared?
- Over the past 10 years, ENLV delivered -54.76% and SNGX delivered -57.62% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Enlivex Therapeutics ROESoligenix ROEEnlivex Therapeutics operating marginSoligenix operating marginEnlivex Therapeutics revenue growthSoligenix revenue growthEnlivex Therapeutics free cash flowSoligenix free cash flow
Enlivex Therapeutics & Soligenix appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.